{"entity":{"id":"e1ae7062-108c-5c6e-9774-1e70d366e15f","name":"Huber Martin H. Jr.","type":"Person","kind":"person","jurisdiction":"US","identifier":"sec:0001653276","risk":"LOW","flags":[]},"identity":{"linked_records":[],"also_known_in":[]},"ownership":{"direct_owners":[],"holdings":[{"role":"director","share":null,"asset":{"id":"6bf1b313-1d8f-5b91-99ed-9315f51eef71","name":"Syndax Pharmaceuticals Inc","type":"Company","kind":"company"}},{"role":"officer","share":null,"asset":{"id":"4edf03d1-5dc7-5d54-bee4-8e5ea9d963bc","name":"Mersana Therapeutics, Inc.","type":"Company","kind":"company"}}],"ubo_chain":[]},"risk":{"level":"LOW","flags":[],"note":"Risk is a layer-1 signal (offshore-layering / connectivity heuristics) — an investigative lead, not a determination."},"sources":[{"registry":"sec_edgar","source_url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001653276"}],"source":"corpus"}